We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

54 hedge funds and large institutions have $10.5M invested in Abeona Therapeutics in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

4% more funds holding

Funds holding: 52 → 54 (+2)

0.23% less ownership

Funds ownership: 1.12% → 0.89% (-0.23%)

24% less capital invested

Capital invested by funds: $13.7M → $10.5M (-$3.22M)

50% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 16

Holders
54
Holders Change
+2
Holders Change %
+3.85%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
8
Reduced
16
Closed
8
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$6K

Top Buyers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
+$1.07M
2
Renaissance Technologies
Renaissance Technologies
New York
+$40.7K
3
WVP
Worth Venture Partners
New Jersey
+$29.5K
4
HF
HRT Financial
New York
+$27.2K
5
Citigroup
Citigroup
New York
+$23.9K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$878K
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$799K
3
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$509K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$393K
5
JP Morgan Chase
JP Morgan Chase
New York
-$340K
Name Holding Trade Value Shares
Change 		Change in
Stake
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$2.52M – – –
ACM
2
AIGH Capital Management
Maryland
$1.58M +$1.07M +155,513 +342%
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$1.01M – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$733K +$40.7K +5,928 +7%
KCM
5
Knoll Capital Management
Florida
$709K – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$703K -$393K -57,209 -39%
D.E. Shaw & Co
7
D.E. Shaw & Co
New York
$641K -$133K -19,380 -19%
BlackRock
8
BlackRock
New York
$534K +$21.1K +3,068 +5%
WVP
9
Worth Venture Partners
New Jersey
$392K +$29.5K +4,300 +9%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$259K +$2.8K +408 +1%
Millennium Management
11
Millennium Management
New York
$225K -$30.6K -4,451 -13%
IA
12
IFP Advisors
Florida
$175K +$2.75K +400 New
Deutsche Bank
13
Deutsche Bank
Germany
$126K – – –
Franklin Resources
14
Franklin Resources
California
$102K – – –
State Street
15
State Street
Massachusetts
$95K – – –
PF
16
Phoenix Financial
Israel
$91K – – –
Assenagon Asset Management
17
Assenagon Asset Management
Luxembourg
$69K -$799K -116,330 -93%
Northern Trust
18
Northern Trust
Illinois
$58K -$330 -48 -0.7%
Morgan Stanley
19
Morgan Stanley
New York
$55K -$878K -127,818 -95%
KPW
20
Kore Private Wealth
New York
$49K – – –
HF
21
HRT Financial
New York
$31K +$27.2K +3,962 New
Citadel Advisors
22
Citadel Advisors
Florida
$29K -$65.6K -9,549 -72%
WM
23
WS Management
Florida
$29K – – –
Citigroup
24
Citigroup
New York
$27K +$23.9K +3,477 New
MIFH
25
Migdal Insurance & Financial Holdings
Israel
$24K -$3.27K -476 -13%
1
2 3

ABEO Hedge Fund Activity: Q1 2022 in Review

54 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2022, worth a combined $10.5M — down 24% from $13.7M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ABEO positions and 8 closed out — a net gain of 2 holders — while 8 added to existing stakes and 16 trimmed.

The largest buyer was AIGH Capital Management, adding an estimated $1.07M. The largest seller was Morgan Stanley, cutting an estimated $878K.

  • 54 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2022, up from 52 in Q4 2021.
  • Funds reported $10.5M of Abeona Therapeutics stock for Q1 2022, down 24% quarter-over-quarter.
  • 10 funds opened new Abeona Therapeutics positions in Q1 2022 and 8 closed out, a net change of +2 holders.
  • The largest Abeona Therapeutics buyer in Q1 2022 was AIGH Capital Management, an estimated $1.07M added.
  • The largest Abeona Therapeutics seller in Q1 2022 was Morgan Stanley, an estimated $878K sold.

Based on aggregated 13F filings for Q1 2022.